Catherine Hess
Catherine Hess rejoined the NASHP staff as a part time Policy Fellow in May, 2016 to work on the State Innovation Model (SIM) evaluation. She previously was part of the NASHP team from 2005 to 2015, starting as a Senior Program Director and eventually serving as the Managing Director for Coverage and Access. She worked with teams of staff to develop and implement initiatives focused on children’s coverage, eligibility and enrollment, access to care and the safety net, dental care, maternal and child health, population health, and health care reform among other areas.
Before joining NASHP, Ms. Hess served for 14 years as the first Executive Director for the Association of Maternal and Child Health Programs (AMCHP), which represents state public health officials. Prior to developing the AMCHP national organization, Ms. Hess served as Policy Director for the Massachusetts Department of Public Health’s Division of Family Health Services, where among other accomplishments, she was key in creating Healthy Start, a cutting edge state funded maternity care insurance program. She is the recipient of numerous awards, and has participated in many national committees and task forces. She holds a bachelor’s degree from the University of Rochester, and a master’s in social work from Boston University.
[PostsByAuthor]

For individuals living with complex, often chronic conditions, and their families, palliative care can provide relief from symptoms, improve satisfaction and outcomes, and help address critical mental and spiritual needs during difficult times. Now more than ever, there is growing recognition of the importance of palliative care services for individuals with serious illness, such as advance care planning, pain and symptom management, care coordination, and team-based, multi-disciplinary support. These services can help patients and families cope with the symptoms and stressors of disease, better anticipate and avoid crises, and reduce unnecessary and/or unwanted care. While this model is grounded in evidence that demonstrates improved quality of life, better outcomes, and reduced cost for patients, only a fraction of individuals who could benefit from palliative care receive it. 























































































































































